Population based screening for the prevention of rheumatic heart disease - Dr Daniel Engelman
Rheumatic heart disease (RHD) is a major cause of global morbidity and mortality, particularly affecting children and young adults in resource-limited settings. Most individuals are diagnosed at an advanced stage of disease, limiting opportunities for prevention. Population-based screening has the potential to detect individuals in an earlier, latent stage of disease, where secondary prevention may be most effective.
Follow Dr Engleman's Work
